Federal health regulators say they’ll update the hemp industry on their CBD review by late summer or fall. Dr. Amy Abernethy, who leads the U.S.... FDA to provide update on CBD review by late summer or fall, official says

Federal health regulators say they’ll update the hemp industry on their CBD review by late summer or fall.

Dr. Amy Abernethy, who leads the U.S. Food and Drug Administration’s work group on cannabinoids such as CBD, said Friday the agency is “enthusiastic about research into the therapeutic benefits of CBD products but also need to balance safety.”

She added the public has until Tuesday to weigh in on how CBD should be allowed in foods and dietary supplements.

“We plan to report on our progress around end of summer/early fall,” she wrote on Twitter.

The FDA has made no promises about expanding CBD access. But the agency has said it is open to changes and started its review May 31.

Subscribe to our Newsletter

MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers

No comments so far.

Be first to leave comment below.

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )